Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TXG

10x Genomics Inc

Nov 27 • 04:00PM ET

42.71

Dollar change -0.65
Percentage change -1.50	%

Healthcare • Health Information Services • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.91	Insider Own	20.13%	Shs Outstand	96.53M	Perf Week	1.28%
Market Cap	5.05B	Forward P/E	-	EPS next Y	-1.44	Insider Trans	-0.55%	Shs Float	94.41M	Perf Month	14.53%
Income	-223.36M	PEG	-	EPS next Q	-0.37	Inst Own	74.67%	Short Float / Ratio	6.02% / 5.84	Perf Quarter	-9.59%
Sales	590.98M	P/S	8.54	EPS this Y	-44.49%	Inst Trans	-1.01%	Short Interest	5.68M	Perf Half Y	-19.23%
Book/sh	6.30	P/B	6.77	EPS next Y	31.77%	ROA	-22.97%	Target Price	54.83	Perf Year	17.21%
Cash/sh	3.02	P/C	14.13	EPS next 5Y	-	ROE	-29.37%	52W Range	31.28 - 63.57	Perf YTD	17.21%
Dividend	-	P/FCF	-	EPS past 5Y	-49.26%	ROI	-26.79%	52W High	-32.81%	Beta	1.88
Dividend %	-	Quick Ratio	4.60	Sales past 5Y	52.97%	Gross Margin	64.40%	52W Low	36.54%	ATR	1.86
Employees	1243	Current Ratio	5.37	Sales Q/Q	17.22%	Oper. Margin	-32.46%	RSI (14)	58.65	Volatility	3.50% 4.76%
Optionable	Yes	Debt/Eq	0.13	EPS Q/Q	-115.03%	Profit Margin	-37.80%	Rel Volume	0.54	Prev Close	43.36
Shortable	Yes	LT Debt/Eq	0.12	Earnings	Nov 02 AMC	Payout	-	Avg Volume	972.35K	Price	42.71
Recom	2.00	SMA20	9.90%	SMA50	6.54%	SMA200	-13.75%	Volume	524,169	Change	-1.50%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-10-23	Initiated	Barclays	Overweight	$65
Mar-31-23	Initiated	Stephens	Overweight	$65
Feb-02-23	Initiated	UBS	Neutral	$50
Dec-14-22	Initiated	Deutsche Bank	Buy	$50
Aug-18-22	Downgrade	Goldman	Neutral → Sell	$55 → $35
Jul-25-22	Initiated	Canaccord Genuity	Buy	$55
Jul-15-22	Downgrade	William Blair	Outperform → Mkt Perform
Jul-15-22	Downgrade	BofA Securities	Neutral → Underperform	$35
Oct-15-21	Resumed	Cowen	Outperform	$205
Sep-14-21	Downgrade	BofA Securities	Buy → Neutral	$180
Mar-15-21	Initiated	William Blair	Outperform
Dec-02-20	Initiated	Goldman	Neutral	$150
Sep-09-20	Initiated	Morgan Stanley	Overweight	$135
Jul-10-20	Initiated	Stifel	Buy	$105
Mar-05-20	Initiated	Guggenheim	Buy	$96
Jan-07-20	Initiated	Citigroup	Buy	$100
Oct-07-19	Initiated	JP Morgan	Overweight	$55
Oct-07-19	Initiated	Cowen	Outperform	$55
Oct-07-19	Initiated	BofA/Merrill	Buy	$62

Show Previous Ratings

Nov-23-23 11:05AM	Insider Sell Alert: Chief Commercial Officer James Wilbur Sells Shares of 10x Genomics Inc (GuruFocus.com)
Nov-19-23 09:08AM	Harvard University Stocks List: Top 12 Picks (Insider Monkey)
Nov-17-23 05:22PM	10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies (PR Newswire) +5.58%
Nov-09-23 01:12AM	Here's Why You Should Invest in 10x Genomics (TXG) (Insider Monkey)
Nov-06-23 04:05PM	OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study (PR Newswire)
11:09AM	Loading…
Nov-03-23 11:09AM	10x Genomics, Inc. (NASDAQ:TXG) Q3 2023 Earnings Call Transcript (Insider Monkey) +8.73%
09:14AM	Q3 2023 10X Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-02-23 07:43PM	10x Genomics Inc (TXG) Reports 17% Revenue Increase in Q3 2023 (GuruFocus.com) +6.44%
07:30PM	10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
04:52PM	10x Genomics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports Third Quarter 2023 Financial Results (PR Newswire)
Nov-01-23 04:05PM	10x Genomics to Present at the Stephens 25th Annual Conference (PR Newswire)
Oct-31-23 10:01AM	Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-30-23 03:45PM	Top 5 Genomics Companies in the World (Insider Monkey)
Oct-26-23 04:05PM	Study Fueled by Xenium Analysis Sheds Light on Resistance Mechanisms in Model of Lethal Pediatric Brain Tumors (PR Newswire)
04:05PM	Loading…
Oct-11-23 04:05PM	10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023 (PR Newswire)
Oct-10-23 12:06PM	10x Genomics Comments on Second UPC Preliminary Injunction Decision (PR Newswire)
Sep-28-23 08:23AM	iRhythm Technologies (IRTC) Moves 7.4% Higher: Will This Strength Last? (Zacks)
Sep-19-23 01:08PM	10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe (PR Newswire)
Sep-18-23 11:52AM	Unveiling 10x Genomics (TXG)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com) -7.12%
Sep-14-23 04:36PM	10x Genomics Expands Gene Expression Flex Offering with New High-Throughput Multiomic Profiling Kit (PR Newswire)
Sep-08-23 07:37PM	10x Genomics (TXG)'s True Worth: A Comprehensive Analysis of Its Market Value (GuruFocus.com) -5.62%
Sep-05-23 09:00AM	Study Enabled by 10x Genomics Single Cell and Spatial Technologies Explains Why Immunotherapy is More Effective for Certain Brain Tumors Than Others (PR Newswire)
Aug-30-23 04:05PM	10x Genomics to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (PR Newswire)
Aug-29-23 04:30PM	10x Genomics Surpasses 100 Xenium Analyzer Shipments (PR Newswire)
Aug-09-23 07:14AM	We're Not Very Worried About 10x Genomics' (NASDAQ:TXG) Cash Burn Rate (Simply Wall St.)
Aug-04-23 04:10PM	Highflier 10x Genomics Sacrifices Breakout As Macro Headwinds Squeeze China (Investor's Business Daily)
Aug-03-23 10:00PM	10x Genomics (TXG) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
06:45PM	10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:40PM	10x Genomics: Q2 Earnings Snapshot (AP Finance)
04:46PM	Loading…
04:46PM	Buy-Zone-Adjacent 10x Genomics Tops Sales Views, But There's A Caveat (Investor's Business Daily)
04:05PM	10x Genomics Reports Second Quarter 2023 Financial Results (PR Newswire)
Jul-13-23 04:05PM	10x Genomics to Report Second Quarter 2023 Financial Results on August 3, 2023 (PR Newswire)
Jul-05-23 07:30PM	CAR T-Cell Study Enabled by 10x Genomics Single Cell Technology Published in Nature Medicine (PR Newswire) -5.01%
Jun-01-23 09:00AM	10x Genomics Files Two New Lawsuits Requesting Preliminary Injunctions Against NanoString's CosMx Products (PR Newswire)
May-25-23 11:43AM	How 10x Genomics Provides A View Into The Body's Cellular Warfare (Investor's Business Daily)
May-24-23 04:05PM	10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay (PR Newswire)
12:30PM	10x Genomics, Inc. (NASDAQ:TXG) Not Flying Under The Radar (Simply Wall St.)
May-18-23 02:57PM	Why Are NanoString Technologies Shares Falling Today (Benzinga)
11:37AM	Why Shares of NanoString Technologies Are Falling Thursday (Motley Fool)
May-17-23 04:05PM	10x Genomics Wins Permanent Injunction Against NanoString's CosMx Products (PR Newswire)
May-14-23 04:05PM	3 DNA Stocks to Buy for the Synthetic Biology Revolution (InvestorPlace)
May-04-23 06:44AM	Q1 2023 10X Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
May-03-23 05:45PM	10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	10x Genomics Reports First Quarter 2023 Financial Results (PR Newswire)
Apr-27-23 12:25PM	A Look At The Fair Value Of 10x Genomics, Inc. (NASDAQ:TXG) (Simply Wall St.)
Apr-25-23 04:06PM	10x Genomics to Present at the BofA Securities 2023 Healthcare Conference (PR Newswire) -6.10%
Apr-12-23 04:05PM	10x Genomics to Report First Quarter 2023 Financial Results on May 3, 2023 (PR Newswire)
Apr-11-23 07:13AM	10x Genomics, Inc. (NASDAQ:TXG) Is Expected To Breakeven In The Near Future (Simply Wall St.)
Mar-07-23 09:15AM	NextGen (NXGN) Riding on the Success of Cloud-Based Solution (Zacks)
Mar-02-23 05:47AM	We're Hopeful That 10x Genomics (NASDAQ:TXG) Will Use Its Cash Wisely (Simply Wall St.)
Feb-22-23 04:30PM	10x Genomics to Present at the 43rd Annual Cowen Healthcare Conference (PR Newswire)
Feb-16-23 07:13PM	10x Genomics, Inc. (NASDAQ:TXG) Q4 2022 Earnings Call Transcript (Insider Monkey) +11.15%
Feb-15-23 05:25PM	10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	10x Genomics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Outlook for 2023 (PR Newswire)
Feb-09-23 10:01AM	Earnings Preview: Syneos Health (SYNH) Q4 Earnings Expected to Decline (Zacks)
Feb-08-23 10:00AM	10x Genomics (TXG) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks) -5.07%
Feb-06-23 09:00AM	10x Genomics Demonstrates Breadth, Scale and Leadership at 2023 AGBT General Meeting (PR Newswire)
Feb-02-23 12:58PM	3 CRISPR Stocks to Buy Now Or Youll Be Kicking Yourself Later (InvestorPlace)
Jan-19-23 04:05PM	10x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023 (PR Newswire)
Jan-17-23 04:10AM	3 Medical Info Systems Stocks Braving Industry-wide Headwinds (Zacks)
Jan-10-23 12:02PM	10x Genomics toolkit at the fulcrum of innovation, CEO says (Yahoo Finance Video)
Dec-28-22 04:05PM	10x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-22-22 07:03AM	10x Genomics (NASDAQ:TXG) adds US$133m to market cap in the past 7 days, though investors from a year ago are still down 75% (Simply Wall St.)
Dec-08-22 04:05PM	10x Genomics Commercially Launches Xenium Platform for In Situ Analysis (PR Newswire) +7.27%
Dec-06-22 05:42PM	East Bay startup Infinimmune's secret for building better antibody drugs: You (American City Business Journals)
Dec-01-22 05:28AM	At US$38.66, Is It Time To Put 10x Genomics, Inc. (NASDAQ:TXG) On Your Watch List? (Simply Wall St.)
Nov-09-22 04:05PM	10x Genomics Launches BEAM to Improve and Streamline Antibody and T-Cell Receptor Discovery (PR Newswire) -6.08%
06:14AM	10x Genomics Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-04-22 07:24PM	Heres Why 10x Genomics (TXG) Underperformed in the Third Quarter (Insider Monkey)
11:37AM	10x Genomics, Inc.'s (NASDAQ:TXG) Intrinsic Value Is Potentially 99% Above Its Share Price (Simply Wall St.)
Nov-02-22 05:45PM	10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	10x Genomics Reports Third Quarter 2022 Financial Results (PR Newswire)
Nov-01-22 02:37PM	Will 10x Genomics Disappoint Investors Again? (TheStreet.com)
Oct-31-22 04:05PM	10x Genomics to Host Investor Day on December 8, 2022 (PR Newswire)
Oct-24-22 11:04AM	Pacific Biosciences' Tools Expansion Doesn't Guarantee Success (TheStreet.com)
Oct-12-22 04:05PM	10x Genomics to Report Third Quarter Financial Results on November 2, 2022 (PR Newswire)
Oct-07-22 10:00AM	Got $2,000? Consider Buying These 2 Beaten-Down Cathie Wood Stocks at Your Own Risk (Motley Fool) -8.87%
Oct-03-22 08:20PM	A Strong Dollar Could Whack These Biotech Stocks (TheStreet.com)
Sep-23-22 06:04AM	10x Genomics (NASDAQ:TXG) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Sep-15-22 09:39AM	Harvard Universitys Latest Portfolio: 10 Best Biotech Stock Picks (Insider Monkey)
Sep-12-22 07:48AM	Inspire (INSP) Stock Jumps 5.6%: Will It Continue to Soar? (Zacks)
Sep-02-22 04:05PM	10x Genomics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference (PR Newswire)
Aug-18-22 09:14AM	10 Cathie Wood Stocks to Buy Before the Bull Run Starts (Insider Monkey) -8.21%
Aug-13-22 08:29AM	What Kind Of Shareholders Hold The Majority In 10x Genomics, Inc.'s (NASDAQ:TXG) Shares? (Simply Wall St.)
Aug-08-22 06:45PM	10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:49PM	Layoffs hit East Bay biotech research tools company as it aims to become more 'resilient' (American City Business Journals)
04:05PM	10x Genomics Reports Second Quarter 2022 Financial Results (PR Newswire)
Aug-02-22 10:00AM	Analysts Estimate Azenta (AZTA) to Report a Decline in Earnings: What to Look Out for (Zacks)
Aug-01-22 10:00AM	Analysts Estimate 10x Genomics (TXG) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-29-22 03:08PM	10x Genomics Stock Rebound Depends on Growth (TheStreet.com)
Jul-28-22 04:05PM	10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit (PR Newswire)
03:40PM	Cathie Woods Top 10 Buys in July (Insider Monkey)
Jul-19-22 01:51PM	From Illumina to Twist Bioscience, a Strong Dollar Is Bad News (TheStreet.com)
Jul-15-22 04:21PM	10X Genomics Stock Got Crushed. Heres Why. (Barrons.com) -17.07%
04:08PM	10x Genomics Crashes On Sales Disappointment, Extending A Yearlong sell-off (Investor's Business Daily)
11:09AM	10x Genomics stock suffering record drop toward record low after revenue warnings prompts downgrade (MarketWatch)
Jul-14-22 05:00PM	10X Genomics Reports Q2 Preliminary Revenues, Shares Plummet On Missing Street Expectation (Benzinga) -7.74%
04:31PM	10x Genomics stock falls as revenue forecast disappoints (MarketWatch)
04:06PM	10x Genomics Names Jim Wilbur as Chief Commercial Officer (PR Newswire)

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saxonov Serge	Chief Executive Officer	Nov 24	Sale	43.72	3,723	162,751	847,446	Nov 27 06:15 PM
Saxonov Serge	Chief Executive Officer	Nov 22	Sale	43.34	3,757	162,816	851,169	Nov 27 06:15 PM
Wilbur James	Chief Commercial Officer	Nov 22	Sale	43.34	3,464	150,118	83,342	Nov 27 06:18 PM
Hindson Benjamin J.	See Remarks	Nov 22	Sale	43.34	3,449	149,468	277,338	Nov 27 06:16 PM
McAnear Justin J.	Chief Financial Officer	Nov 22	Sale	43.34	1,679	72,762	97,105	Nov 27 06:15 PM
Wilbur James	Chief Commercial Officer	Nov 20	Sale	42.09	14,718	619,494	86,806	Nov 22 04:30 PM
Saxonov Serge	Chief Executive Officer	Nov 14	Sale	39.52	2,000	79,041	854,926	Nov 16 04:22 PM
Saxonov Serge	Chief Executive Officer	Oct 17	Sale	39.51	1,979	78,187	856,926	Oct 18 04:33 PM
Saxonov Serge	Chief Executive Officer	Oct 16	Sale	39.50	21	830	858,905	Oct 18 04:33 PM
Saxonov Serge	Chief Executive Officer	Sep 14	Sale	49.37	2,000	98,739	862,093	Sep 18 04:43 PM
Wilbur James	Chief Commercial Officer	Aug 22	Sale	45.78	9,699	444,031	101,253	Aug 24 05:08 PM
Saxonov Serge	Chief Executive Officer	Aug 22	Sale	45.78	3,757	172,000	864,093	Aug 24 05:11 PM
Hindson Benjamin J.	See Remarks	Aug 22	Sale	45.78	3,449	157,899	280,787	Aug 24 05:08 PM
McAnear Justin J.	Chief Financial Officer	Aug 22	Sale	45.78	1,678	76,821	98,784	Aug 24 05:09 PM
Saxonov Serge	Chief Executive Officer	Aug 14	Sale	50.11	2,000	100,212	867,850	Aug 16 05:11 PM
Hindson Benjamin J.	See Remarks	Aug 01	Option Exercise	11.48	6,970	80,016	291,206	Aug 03 04:23 PM
Hindson Benjamin J.	See Remarks	Aug 01	Sale	62.21	6,970	433,612	284,236	Aug 03 04:23 PM
Saxonov Serge	Chief Executive Officer	Jul 19	Option Exercise	5.04	20,845	105,059	909,850	Jul 21 05:32 PM
Hindson Benjamin J.	See Remarks	Jul 19	Option Exercise	5.49	13,940	76,492	298,176	Jul 21 05:31 PM
Saxonov Serge	Chief Executive Officer	Jul 19	Sale	60.03	40,000	2,401,088	869,850	Jul 21 05:32 PM
Hindson Benjamin J.	See Remarks	Jul 19	Sale	60.03	13,940	836,834	284,236	Jul 21 05:31 PM
Saxonov Serge	Chief Executive Officer	Jul 14	Sale	58.05	2,000	116,090	889,005	Jul 18 06:26 PM
Saxonov Serge	Chief Executive Officer	Jun 14	Sale	58.16	2,000	116,328	891,005	Jun 16 05:37 PM
STUELPNAGEL JOHN R	Director	Jun 05	Sale	54.89	10,000	548,894	333,736	Jun 07 06:32 PM
Saxonov Serge	Chief Executive Officer	May 23	Sale	55.06	2,602	143,271	893,190	May 23 07:51 PM
Hindson Benjamin J.	See Remarks	May 23	Sale	55.06	2,388	131,487	284,236	May 25 05:49 PM
McAnear Justin J.	Chief Financial Officer	May 23	Sale	55.06	1,665	91,682	100,462	May 25 05:48 PM
Wilbur James	Chief Commercial Officer	May 23	Sale	55.07	316	17,401	110,952	May 25 05:49 PM
Saxonov Serge	Chief Executive Officer	May 15	Sale	53.35	2,000	106,702	895,792	May 17 04:35 PM
Mammen Mathai	Director	May 11	Option Exercise	1.16	200,000	232,000	202,745	May 15 04:37 PM
Mammen Mathai	Director	May 11	Sale	52.82	33,000	1,743,086	169,745	May 15 04:37 PM
Saxonov Serge	Chief Executive Officer	Apr 14	Sale	53.82	2,000	107,640	897,792	Apr 18 04:39 PM
Saxonov Serge	Chief Executive Officer	Mar 14	Sale	48.88	2,000	97,756	863,405	Mar 16 04:27 PM
Saxonov Serge	Chief Executive Officer	Feb 22	Sale	47.75	1,941	92,689	909,715	Feb 24 05:51 PM
Hindson Benjamin J.	See Remarks	Feb 22	Sale	47.75	1,742	83,186	250,237	Feb 24 05:51 PM
McAnear Justin J.	Chief Financial Officer	Feb 22	Sale	47.75	1,245	59,453	75,519	Feb 24 05:53 PM
Hindson Benjamin J.	See Remarks	Dec 14	Option Exercise	5.04	34,266	172,701	251,979	Dec 16 04:46 PM
Saxonov Serge	Chief Executive Officer	Dec 12	Option Exercise	1.20	3,000	3,600	911,656	Dec 14 04:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TXG

10x Genomics Inc

Upgrade your FINVIZ experience